-
Samsung Biologics Expands Global Footprint
contractpharma
November 02, 2020
Samsung Biologics has opened its first U.S. CDO R&D Center in San Francisco, CA, bringing its contract development services closer to global clients.
-
Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center
prnasia
October 29, 2020
At a virtual ceremony today, Samsung Biologics announced the grand opening of its first US CDO R&D Center in San Francisco, bringing its contract development services closer to global clients.
-
Samsung Biologics and ImmuneOncia Expand Partnership
contractpharma
July 16, 2020
Sign multi-product development and manufacturing agreement for five candidate molecules.
-
Samsung Biologics Appoints BD VP for CDO Biz
contractpharma
April 01, 2020
Ms. Yang brings 20 years of experience in marketing, sales, and business development at global pharmaceutical companies.
-
Samsung Biologics signs contract with GI Innovation
biospectrumasia
May 06, 2019
GI Innovation signed this second contract with Samsung BioLogics based on their satisfaction with the high quality and production services received during their first project with Samsung BioLogics in June of last year.
-
Samsung Biologics Signs CDO Deal with Eutilex
firstwordpharma
March 21, 2019
Samsung Biologics signed on March 20 a contract development organization (CDO) agreement with Eutilex for developing cancer immunotherapy medicine.
-
Genmab Appoints CDO
contractpharma
February 09, 2017
Klimovsky to lead Genmab’s product development strategy